Net Income

A traditional Chinese steel manufacturer is pivoting to the high-stakes world of clean energy. Can it transform its industrial might into a green future?

A new blood test could tell you if GLP-1 drugs will work for you before you start, a major leap for precision medicine in the booming obesity market.

Sensei Biotherapeutics begins a key trial for PIKTOR, a novel oral therapy aiming to outsmart cancer resistance in patients with advanced breast cancer.

Minerva Neurosciences launches a pivotal Phase 3 trial for roluperidone, a potential first-in-class drug for the untreated negative symptoms of schizophrenia.

The WPO's 50 Fastest list reveals women-owned businesses are not just growing, they're setting new standards for innovation and economic impact.

The healthy meal company is betting on 'better-for-you' comfort food with a QVC debut of classic pizzas, aiming to redefine the frozen food market.

Schindler's new ReStore and ReNew packages offer a cost-effective, high-tech upgrade for aging hydraulic elevators, boosting efficiency and reliability.

New research reveals AI is not just hype for manufacturers. Early adopters see real value in months, leaving hesitant competitors far behind.

As unmanaged AI agents create a new security crisis, SlashID launches a platform to govern non-human access and rein in the risks of 'Shadow AI'.

Cambridge Savings is acquiring NH's First Seacoast Bancorp in a deal that expands its footprint and signals major consolidation in regional community banking.

Following a landmark FDA approval and strong earnings, Axsome must convince investors its momentum can translate into long-term profitability and leadership.

A new biotech emerges with a promising, late-stage gene therapy for Sanfilippo syndrome, offering a potential lifeline for children with no other options.

With profits up and a new CEO, TVA is pouring billions into new generation, betting on advanced nuclear power to meet soaring demand from data centers.

Atkore's Q2 revenue rose 4.2%, but a $136.5M antitrust settlement drove a major net loss. The company divests assets to focus on its electrical core.

Operational failures at a key new mine pushed Peabody to a Q1 loss, overshadowing strong thermal coal profits fueled by geopolitical conflict.

The utility giant posted strong first-quarter earnings, driven by surging industrial demand, and reaffirmed its outlook amid a historic investment plan.

The ticket marketplace saw revenue fall year-over-year, but a surge in cash flow and sequential growth offers a potential path to recovery.

A new drug, CS-1103, earns FDA Fast Track to combat fentanyl overdoses by binding and removing the opioid, a potential game-changer over naloxone.

Enlight Renewable Energy posts strong Q1 results, with underlying profits surging 76% despite a misleading net income dip, and reaffirms its 2026 outlook.

A new report reveals U.S. firms lead in security spending intent but lag in AI deployment, creating a dangerous gap between belief and reality.